This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Roche Sequencing Solutions, Inc.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Inventor Spotlight: Kunchala Rungsrisuriyachai
Introduction
Kunchala Rungsrisuriyachai is a notable inventor based in Dublin, California, with a significant contribution to the field of nucleic acid research. His innovative work has led to the development of a novel method aimed at isolating long nucleic acids, which holds great potential for advancements in sequencing technologies.
Latest Patents
Kunchala holds one patent titled "Method of Isolating Nucleic Acids for Long Sequencing Reads." This invention focuses on a unique approach to isolating long nucleic acids from various samples, enhancing the capability of nucleic acid sequencing. The method is particularly effective in extracting low-concentration nucleic acids, such as viral nucleic acids from clinical samples, which can be critical for diagnostic purposes and research.
Career Highlights
Currently, Kunchala is employed at Roche Sequencing Solutions, Inc., a leading company that specializes in genomic solutions and technologies. His role at Roche has allowed him to contribute to pioneering research in the field, ultimately aiming to improve patient outcomes through advanced sequencing techniques.
Collaborations
Throughout his career, Kunchala has collaborated with colleagues including Monica Herrera and Jenny A. Johnson. These collaborations have fostered a dynamic exchange of ideas and innovation, further driving the success of his projects within the company.
Conclusion
Kunchala Rungsrisuriyachai exemplifies the vital role of inventors in advancing scientific knowledge and technology. His inventive spirit and dedication to improving nucleic acid isolation techniques pave the way for future breakthroughs in sequencing, making a substantial impact on both research and clinical practices.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
